))
Welcome to AI Uncovered, a podcast for technology enthusiasts that explores the intersection of generative AI, machine learning, and innovation across regulated industries. With the AI software market projected to reach $14 trillion by 2030, each episode features compelling conversations with an innovator exploring the impact of generative AI, LLMs, and other rapidly evolving technologies across their organization. Hosted by Executive VP of Product at Yseop, Tim Martin leads a global team an ...
…
continue reading
1
Oeystein Kjoersvik - Auditing AI: Quality, Compliance & the Role of GenAI in Pharma
32:51
32:51
Play later
Play later
Lists
Like
Liked
32:51
We’re excited to welcome Oeystein Kjoersvik to AI Uncovered. Oeystein leads the Generative AI program within the Quality Assurance team at Merck, where he focuses on developing AI tools and applying a quality-first approach to ensure safe, effective use of AI in GxP-regulated environments. In this episode, Tim and Oeystein delve into the challenges…
…
continue reading
1
Emmanuel Walckenaer: AI’s Real-World Impact on Pharma & What’s Next in 2025
23:56
23:56
Play later
Play later
Lists
Like
Liked
23:56
We’re thrilled to welcome Emmanuel Walckenaer, CEO of Yseop, back to AI Uncovered for a follow-up conversation on the rapid evolution of AI in biopharma. Since his last appearance, the industry has made significant strides in harnessing AI for regulatory submissions, clinical workflows, and medical writing—areas where Yseop is leading the charge in…
…
continue reading
1
Meredith Brown-Tuttle: AI’s Impact on Global Regulatory Strategy and the Future of Pharma
28:46
28:46
Play later
Play later
Lists
Like
Liked
28:46
We welcome Meredith Brown-Tuttle to AI Uncovered. Meredith is the Chief Regulatory Strategist at Regulatorium, where she applies her 33 years of experience in the pharmaceutical and biologics industry. She specializes in working with small and medium-sized drug, biologic and combination product companies to navigate global regulatory strategy, inte…
…
continue reading
1
Michael Penlington - Impact of AI and New Standards in Clinical Trials
43:19
43:19
Play later
Play later
Lists
Like
Liked
43:19
We welcome Michael Penlington to AI Uncovered. Michael has been working in Pharma for his entire career including roles in leading development of Vaccines and Clinical reporting at Novartis, as well as Senior Director roles of Science writing, Global Medical Writing and Medical Writing Center of Excellence at GSK. Most recently, Michael has taken o…
…
continue reading
1
Rohit Sood - Digital Transformation & AI's Role in Life Sciences
44:54
44:54
Play later
Play later
Lists
Like
Liked
44:54
We welcome Rohit Sood to AI Uncovered. Rohit is a seasoned executive with a strong background in commercialization and technology use in life sciences. He currently advises a variety of life science services and Private Equity firms on operations, growth and digital transformation. With over 25 years of experience in the life sciences and technolog…
…
continue reading
1
Fred Schonenberg - The Vital Role of GenAI in Enterprises
37:22
37:22
Play later
Play later
Lists
Like
Liked
37:22
We welcome Fred Schonenberg to AI Uncovered. Fred is the founder and CEO of VentureFuel. He has created an innovation framework that bridges the VC, Angel, and Startup ecosystem with enterprises to deliver tangible technology solutions that drive growth. In his role at Venture Fuel, Fred has worked with over 100 companies from General Mills to Netf…
…
continue reading
Welcome Sarah Tilly to AI Uncovered. Sarah is the Founder and Director of Azur Health Science, a regulatory writing consultancy based in France. Guided by her expertise as a member of the European Medical Writers Association (EMWA), Tim and Sarah discuss what steps are being taken to better understand the benefits of AI for medical writing. Sarah h…
…
continue reading
1
Derek Kerton - AI’s Impact on Automobiles
43:57
43:57
Play later
Play later
Lists
Like
Liked
43:57
We welcome Derek Kerton to AI Uncovered. Derek is the Founder and Chairman of the Autotech Council in Silicon Valley. His work brings global car companies together with startups to drive discussion around new technologies and their possible impact on the car industry. In this episode, Derek shares his expertise with Tim, offering valuable insights …
…
continue reading
1
Daniel O'Mahony - BioPharma 4.0 & The Role of AI in Drug Manufacturing
29:57
29:57
Play later
Play later
Lists
Like
Liked
29:57
We welcome Daniel O'Mahony to AI Uncovered. Daniel is a senior manager of sales and business consulting with Körber Pharma, a pharma manufacturing software company. Along with his work at Körber, Dan lectures with the national institute of bioprocessing research and training and at the Atlantic Technical University covering topics like BioPharma 4.…
…
continue reading
1
Gregor Mittersinker - "AI, ChatGPT, and the Impact on UX & Design"
44:27
44:27
Play later
Play later
Lists
Like
Liked
44:27
We welcome Gregor Mittersinker to AI Uncovered. Gregor is the founder and creative director at Loft. Loft focuses on product development and design with a specialty in building large product ecosystems. In this episode, Tim and Gregor dive deep into UX and design. They discuss how LLMs, like ChatGPT, have impacted UI design, specifically around con…
…
continue reading
1
Marjo Gazak - "What used to take 8 hours, I can now generate a first draft in 1 second"
47:10
47:10
Play later
Play later
Lists
Like
Liked
47:10
We welcome Marjo Gazak to AI Uncovered. Marjo is a life sciences expert with over 22 years of experience in drug development, regulatory submissions, document development innovation and data mining systems. Tim and Marjo discuss a wide range of topics, from the emergence of automation in the drug delivery process to the future role of generative AI…
…
continue reading
1
Emmanuel Walckenaer - "In the next five years, 80% of the life sciences industry will be using this type of AI"
29:01
29:01
Play later
Play later
Lists
Like
Liked
29:01
The second episode features a conversation with Emmanuel Walckenaer, CEO of Yseop. Yseop is reimagining the future of scientific writing through generative AI. The company's mission is to get medicine into the hands of those who need it, faster. Tim and Emmanuel shares insights on the state of natural language generation (NLG) today and the roots o…
…
continue reading
1
Craig Vachon - “I still think ChatGPT is kind of a gimmick”
26:33
26:33
Play later
Play later
Lists
Like
Liked
26:33
The first episode features a conversation with Craig Vachon, CEO of AI Redefined (AIR) and Head of US Operations at NextStage AM. Craig is an angel investor, author, TED speaker, and chairman of Yseop. Tim and Craig discuss the AI landscape as it exists today and then go into the benefits and limitations of ChatGPT and LLMs, especially for more reg…
…
continue reading
Welcome to AI Uncovered, a podcast for technology enthusiasts that explores the intersection of generative AI, machine learning, and innovation across regulated industries. With the AI software market projected to reach $14 trillion by 2030, each episode features compelling conversations with an innovator exploring the impact of generative AI, LLMs…
…
continue reading
